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Brief Clinical ReportsRegional cerebral oxygenation measured by multichannel
near-infrared spectroscopy (optical topography) in an infant
supported on venoarterial extracorporeal membrane oxygenationMaria D. Papademetriou, MSc,a Ilias Tachtsidis, PhD,a Murad Banaji, PhD,a Martin J. Elliott, MD,b
Aparna Hoskote, MD,b and Clare E. Elwell, PhD,a London, United KingdomIn the current era of advanced cardiac surgery and
extracorporeal membrane oxygenation (ECMO), there are
serious limitations with inadequate neuromonitoring, mis-
leading neuromonitoring, or both, especially in the setting
of hemodilution and nonpulsatile flow.1 Multimodal neuro-
logical monitoring is available and advocated in certain
centers.2 However, the implications of neurological moni-
toring with relevance to neurodevelopmental outcome
have not been clearly delineated. As a result, there is equi-
poise about routine neuromonitoring, particularly with
near-infrared spectroscopy (NIRS) and the relevance of
data.3
Single- or dual-channel NIRS has been usedwidely in car-
diac theaters.4 In a previous study we used dual-channel
NIRS in patients undergoing ECMO to understand cerebral
and peripheral tissue oxygenation.5 Power spectral density
analysiswas performed to extract vasomotion and respiratory
and cardiac oscillations. To date, most NIRS studies have
used optodes placed on the forehead, which monitor only
a small area of the anterior cerebrum. We have developed
a novel multichannel NIRS protocol for providing regional
measures of cerebral oxygenation and hemodynamics for
use in cardiac theaters and intensive care units. Because
ECMO in the cardiac intensive care unit could be a surrogate
model similar to a patient undergoing cardiac surgery during
cardiopulmonary bypass, we have carried out preliminary
studies on patients undergoing ECMO during manipulations
in the ECMOcircuit blood flows.We present our preliminary
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The Journal of Thoracic and Cahave identified differences in regional cerebral oxygenation
with changes in ECMO flows.
CLINICAL SUMMARY
In this pilot study an ETG-100 optical topographic
system (Hitachi Medical Ltd, Tokyo, Japan) was used to
measure changes in oxyhemoglobin (HbO2), deoxyhemo-
globin (HHb), and total hemoglobin (HbT ¼ HbO2 þ
HHb) concentrations in a 12-day-old neonate supported
on venoarterial ECMO for severe respiratory failure.
ECMO circuit flow was successively decreased by 10%
from initial flow every 10 to 15 minutes down to 70% of
the initial flow and then gradually brought back to baseline.
A novel neonatal cap was constructed to accommodate the
optical sources and detectors in a 3 3 3 array (interoptode
distance ¼ 3 cm), allowing data to be collected from
12 channels (Figure 1, A). Multimodal data were collected
synchronously with the optical data that included systemic
parameters (arterial blood pressure, heart rate [HR], and
arterial oxygen saturation [SpO2]) and ECMO circuit
parameters (venous oxygen saturation [SvO2]).
Changes in HbO2, HHb, and HbT concentrations be-
tween phase I (from baseline flow [100%] to minimum
flow [70%]) and phase II (from 70% flow back to base-
line) were calculated from the differences in mean values
over a 60-second period immediately before the change
in flow. The results were analyzed with a paired t test
(P< .05).
Figure 1, B, shows concentration changes in HbO2,
HHb, and HbT collected from the 12 channels during
changes in ECMO flows. Significant changes in HHb,
HbO2, and HbT concentrations were seen across all
channels. During phase I, a decrease in ECMO flow was
associated with a substantial increase in HHb concentra-
tions in all channels (range, 9.7 to 25.1 mmol/L). Much
smaller changes were seen in HbO2 concentrations (range,
4.3 to 3.8 mmol/L).
Figure 2 shows the responses of HR, mean arterial
pressure, SpO2, and SvO2 during phases I and II. In this
patient a decrease in flow is associated with a decrease
in SvO2 and SpO2 and an increase in HR and mean arterial
pressure. The effect is reversed when the flow is in-
creased back to baseline values. Similar to hemoglobinrdiovascular Surgery c Volume 141, Number 5 e31
FIGURE 1. A, Schematic of the source-detector array and channel configuration. The photograph shows the UCL-designed neonatal cap in use with each
source (S) and detector (D) annotated. B, Oxyhemoglobin (HbO2), deoxyhemoglobin (HHb), and total hemoglobin (HbT) concentration changes from 12
channels during extracorporeal membrane oxygenation circuit flow changes. The vertical dotted lines represent the time at which a change in flow was in-
duced so that each section in the plots corresponds to a specific flow, as annotated on channel 1: a, baseline (100% flow); b, 90% flow; c, 80% flow; d, 70%
flow; e, 80% flow; f, 90% flow; and g, baseline.
Brief Clinical Reportsconcentrations, these systemic and ECMO parameters do
not return to their baseline values by the end of the mon-
itoring period.
DISCUSSION
This single-patient study showed significant changes
in systemic oxygenation and cerebral hemoglobin concen-e32 The Journal of Thoracic and Cardiovascular Surgtrations in response to modest changes in ECMO flows.
Regional variations were observed between channels 8
and 10, which potentially cover different hemispheres.
Reduction in flows was associated with a decrease in SvO2
and SpO2 suggestive of a decrease in oxygen delivery.
This is reflected in the NIRS data with a significant increase
in HHb concentrations. The lack of a consistence decreaseery c May 2011
FIGURE 2. Mean changes in systemic and extracorporeal membrane oxy-
genationparameters duringphases I and II.HR,Heart rate;MAP,meanarterial
pressure; SpO2, arterial oxygen saturation; SvO2, venous oxygen saturation.
Brief Clinical Reportsin HbO2 concentrations could be explained by a compensa-
tory arterial dilation.
We demonstrate that multichannel optical topographic
analysis can provide information on regional cerebral
hemodynamics and oxygenation in patients supported by
ECMO. Simultaneous measurement of systemic and cere-
bral HbO2 and HHb concentrations can help elucidate
mechanisms related to the response of the brain during
changes in ECMO and cardiopulmonary bypass flows.From the Department of Pediatric Cardiovascular Surgery,a Children’s Research Hospi-
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The Journal of Thoracic and CaIn this patient modest changes in ECMO flows appear to
present a significant hemodynamic challenge to cerebral
circulation. Further work is necessary to support application
of this novel brain-monitoring technology in cardiac
theaters and intensive care units, andwe nowhave a protocol
to further investigate regional brain oxygenation in these
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447-53.Seven-year outcome of pulmonary valve autograft replacement of the
mitral valve in an infantTomohito Kanzaki, MD,a Masaaki Yamagishi, MD, PhD,a Masafumi Yashima, MD,a and
Hitoshi Yaku, MD, PhD,b Kyoto, JapanPulmonary autograft replacement of the mitral valve1 ap-
pears to be a useful alternative for children with irreparable
mitral valve disease. Long-term results, however, have yet
to be reported. We previously reported a case of mitral valve
replacement with a Gore-Tex–reinforced (W. L. Gore &
Associates, Inc, Flagstaff, Ariz) pulmonary autograft in
a child.2 In this report, we described the fate of the
pulmonary autograft 7 years after that operation.CLINICAL SUMMARY
A girl with a partial atrioventricular septal defect and
severe mitral regurgitation underwent pulmonary auto-
graft replacement of the mitral valve when 11 months
old. The pulmonary autograft was anastomosed to an ap-
propriately sized Gore-Tex expanded polytetrafluoroethy-
lene (ePTFE) graft.2 The ePTFE felt strip was looped
around and sewn onto the outer surface of the Gore-Tex
graft as a sewing cuff. The pulmonary autograft with
the ePTFE external cylinder was inserted into the mitral
annulus, and the ePTFE felt band was anastomosed to
the mitral annulus. The implanted valve did not protrude
into either the left ventricle or the left atrium. The oper-
ation was successful, and the patient was further treated
with medications including diuretics, digoxin, and an
angiotensin-converting enzyme inhibitor for treatment of
chronic heart failure. Six years after the operation, an
echocardiogram showed mild mitral regurgitation but no
significant mitral stenosis. A follow-up cardiac catheteri-
zation demonstrated growth of fibrous tissue causing therdiovascular Surgery c Volume 141, Number 5 e33
